Press Releases
Press Releases
Airnov to exhibit range of healthcare packaging solutions at upcoming Connect in Pharma event in Geneva
Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be exhibiting a range of solutions available to customers worldwide at the upcoming Connect in Pharma event, due to be held in Geneva on September 14-15, 2022.
Connect in...
Press Releases
“Genome Editing of Immune Cells” – New Lonza Virtual Event
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and...
Press Releases
ChargePoint Technology Acquires PuroVaso
ChargePoint Technology Group, the powder and liquid transfer specialist and a portfolio company of Arcline Investment Management, has announced the acquisition of PuroVaso, a leader in the design, development, and manufacture of single-use containers, handling equipment and accessories for...
Press Releases
Achema 2022: Syntegon presents new Service Agreements
At this yearโs Achema, Syntegon will present redesigned Service Agreement packages for effective asset and maintenance management at fixed costs. The varied agreements help customers from the pharmaceuticals and food industries to reduce production risks, gain predictability over service...
Clinical Trials
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma
Bristol Myers Squibb and 2seventy bio, Inc.announced positive topline results from KarMMa-3, a Phase 3, global, randomized, multicenter, open-label study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory...
Drug Research
West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a...
Press Releases
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a Post Approval Change Application approval from the Korean Ministry of Food and Drug Safety (KMFDS)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















